Frank C. Schell

604 total citations
14 papers, 502 citations indexed

About

Frank C. Schell is a scholar working on Oncology, Dermatology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Frank C. Schell has authored 14 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 3 papers in Dermatology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Frank C. Schell's work include Cancer Treatment and Pharmacology (8 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Frank C. Schell is often cited by papers focused on Cancer Treatment and Pharmacology (8 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Frank C. Schell collaborates with scholars based in United States, United Kingdom and Spain. Frank C. Schell's co-authors include George R. Blumenschein, Aman U. Buzdar, H. Y. Yap, Gabriel N. Hortobágyi, Eleanor D. Montague, William J. Spanos, Hwee‐Yong Yap, Gerald P. Bodey, Manuel Valdivieso and Sewa S. Legha and has published in prestigious journals such as Annals of Internal Medicine, Cancer and Cancer Chemotherapy and Pharmacology.

In The Last Decade

Frank C. Schell

14 papers receiving 471 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frank C. Schell United States	8	345	285	150	76	62	14	502
Debbie Frye United States	8	396 1.1×	373 1.3×	126 0.8×	68 0.9×	101 1.6×	13	556
Jean-Pierre Ferrière France	14	362 1.0×	307 1.1×	189 1.3×	70 0.9×	63 1.0×	26	571
Günther Raab Germany	8	394 1.1×	465 1.6×	210 1.4×	39 0.5×	62 1.0×	10	605
Mary E. Sears United States	6	262 0.8×	189 0.7×	47 0.3×	42 0.6×	67 1.1×	10	363
G. Raab Germany	7	487 1.4×	483 1.7×	178 1.2×	50 0.7×	81 1.3×	19	650
E Ghislandi Italy	6	383 1.1×	214 0.8×	23 0.2×	49 0.6×	101 1.6×	18	469
S Wolff United States	4	307 0.9×	107 0.4×	74 0.5×	39 0.5×	48 0.8×	6	408
G. S. J. Thynne Australia	7	214 0.6×	84 0.3×	125 0.8×	54 0.7×	85 1.4×	8	344
Marie-Thérèse Closon Belgium	5	420 1.2×	180 0.6×	31 0.2×	23 0.3×	79 1.3×	8	454
BC Lembersky United States	8	295 0.9×	160 0.6×	34 0.2×	47 0.6×	169 2.7×	14	442

Countries citing papers authored by Frank C. Schell

Since Specialization

Citations

This map shows the geographic impact of Frank C. Schell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank C. Schell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank C. Schell more than expected).

Fields of papers citing papers by Frank C. Schell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank C. Schell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank C. Schell. The network helps show where Frank C. Schell may publish in the future.

Co-authorship network of co-authors of Frank C. Schell

This figure shows the co-authorship network connecting the top 25 collaborators of Frank C. Schell. A scholar is included among the top collaborators of Frank C. Schell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank C. Schell. Frank C. Schell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Buzdar, Aman U., George R. Blumenschein, Terry L. Smith, et al.. (1984). Adjuvant chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide, with or without Bacillus Calmette-Guerin and with or without irradiation in operable breast cancer a prospective randomized trial. Cancer. 53(3). 384–389. 58 indexed citations

Tannir, Nizar M., Gary Spitzer, Karel A. Dicke, et al.. (1984). Phase I-II study of high-dose mitomycin with autologous bone marrow transplantation in refractory metastatic breast cancer.. PubMed. 68(5). 805–6. 7 indexed citations

Yap, Hwee‐Yong, et al.. (1983). Bisantrene, an active new drug in the treatment of metastatic breast cancer.. PubMed. 43(3). 1402–4. 26 indexed citations

Tannir, Nizar M., Gary Spitzer, Frank C. Schell, et al.. (1983). Phase II study of high-dose amsacrine (AMSA) and autologous bone marrow transplantation in patients with refractory metastatic breast cancer.. PubMed. 67(6). 599–600. 7 indexed citations

Hortobágyi, Gabriel N., George R. Blumenschein, William J. Spanos, et al.. (1983). Multimodal treatment of locoregionally advanced breast cancer. Cancer. 51(5). 763–768. 190 indexed citations

Yap, H. Y., Agop Y. Bedikian, Frank C. Schell, G. R. Blumenschein, & Gerald P. Bodey. (1983). Phase II clinical evaluation of AZQ in metastatic breast cancer. American Journal of Clinical Oncology. 6(1). 31–33. 1 indexed citations

Yap, H. Y., et al.. (1982). Combination chemotherapy with continuous infusion vinblastine and peptichemio for patients with advanced metastatic breast cancer. American Journal of Clinical Oncology. 5(5). 511–514. 2 indexed citations

Schell, Frank C., et al.. (1982). Phase II study of VP16-213 (Etoposide) in refractory metastatic breast carcinoma. Cancer Chemotherapy and Pharmacology. 7(2-3). 223–5. 40 indexed citations

Spitzer, Gary, S S Legha, L Vellekoop, et al.. (1982). High-dose AMSA and bone marrow rescue in patients with solid tumors.. PubMed. 66(2). 385–6. 9 indexed citations

10.

Buzdar, Aman U., Sewa S. Legha, George R. Blumenschein, et al.. (1982). Peptichemio versus melphalan (L-PAM) in advanced breast cancer. Cancer. 49(9). 1767–1770. 7 indexed citations

11.

Schell, Frank C., et al.. (1981). Phase II evaluation of methyl-GAG in patients with refractory metastatic breast cancer.. PubMed. 65(5-6). 465–7. 7 indexed citations

12.

Yap, Hwee‐Yong, George R. Blumenschein, Frank C. Schell, et al.. (1981). Dihydroxyanthracenedione: A Promising New Drug in the Treatment of Metastatic Breast Cancer. Annals of Internal Medicine. 95(6). 694–697. 79 indexed citations

13.

Hortobagyi, G. N., George R. Blumenschein, Aman U. Buzdar, et al.. (1981). Combination chemoimmunotherapy with FAC‐BCG for metastatic breast cancer: The impact of CMF maintenance chemotherapy. Journal of Surgical Oncology. 18(2). 163–172. 8 indexed citations

14.

Buzdar, Aman U., Sewa S. Legha, Gabriel N. Hortobágyi, et al.. (1981). Management of breast cancer patients failing adjuvant chemotherapy with adriamycin-containing regimens. Cancer. 47(12). 2798–2802. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact